News Conference News ESC 2024 RESHAPE-HF2 Is a Win for MitraClip in FMR—Not Everyone’s On Board Shelley Wood August 31, 2024
News Conference News ESC 2024 Tri.Fr Trial Affirms Quality-of-Life Impact of Tricuspid TEER Todd Neale August 31, 2024
News Daily News Evolut TAVI Shows Promise in Low-risk Bicuspid Patients at 3 Years Yael L. Maxwell July 22, 2024
News Daily News Knowns and Unknowns in Subclinical Aortic Valve Thrombosis Caitlin E. Cox June 21, 2024
News Daily News The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead Michael O'Riordan June 20, 2024
News Conference News NY Valves 2024 Polymer Mitral Valve Shows Well Early, but Long-term Data Key Michael O'Riordan June 12, 2024
News Daily News SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER Michael O'Riordan May 07, 2024
News Opinion Off Script Evoque and Patisiran: A Tale of Two Regulatory Journeys Sanjay Kaul, MD March 29, 2024
News Daily News FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation Michael O'Riordan February 13, 2024
News Daily News FDA Advisors Set to Take on TriClip for TR as TRILUMINATE Questions Loom Michael O'Riordan February 09, 2024
News Daily News FDA Approves First Transcatheter Tricuspid Valve Replacement Device L.A. McKeown February 02, 2024
News Daily News Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest Michael O'Riordan January 30, 2024
News Daily News Lower Mortality With M-TEER vs Surgery, but Devil Is in the Details Michael O'Riordan January 25, 2024
News Opinion Off Script My Hopes for Cardiology in 2024: More Honesty, Humility, and Collaboration Benoy Shah, MBBS, MD(Res) January 24, 2024
News Conference News PCR London Valves 2023 For the Ideal Tricuspid TEER Patient—Look Beyond TRILUMINATE Shelley Wood November 20, 2023
News Conference News TCT 2023 ‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II Michael O'Riordan October 26, 2023